Deafness, Congenital, and Onychodystrophy, Autosomal Dominant
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ATP6V1B2, which encodes the B2 subunit of the vacuolar H + ATPase have previously been associated with Zimmermann-Laband syndrome 2 (ZLS2) and deafness-onychodystrophy (DDOD) syndrome.
|
31655144 |
2019 |
Deafness, Congenital, and Onychodystrophy, Autosomal Dominant
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
We previously identified c.1516C > T (p.Arg506X) in ATP6V1B2 as cause of DDOD syndrome, accounting for all cases of this genetic disorder.
|
31257146 |
2019 |
Deafness, Congenital, and Onychodystrophy, Autosomal Dominant
|
0.620 |
GermlineCausalMutation
|
disease |
ORPHANET |
De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome.
|
24913193 |
2014 |
Deafness, Congenital, and Onychodystrophy, Autosomal Dominant
|
0.620 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Deafness, Congenital, and Onychodystrophy, Autosomal Dominant
|
0.620 |
Biomarker
|
disease |
CTD_human |
|
|
|
Zimmerman Laband syndrome
|
0.610 |
Biomarker
|
disease |
CTD_human |
We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H(+) ATPase, in two individuals with ZLS.
|
25915598 |
2015 |
Zimmerman Laband syndrome
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H(+) ATPase, in two individuals with ZLS.
|
25915598 |
2015 |
Zimmerman Laband syndrome
|
0.610 |
GermlineCausalMutation
|
disease |
ORPHANET |
We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H(+) ATPase, in two individuals with ZLS.
|
25915598 |
2015 |
Zimmerman Laband syndrome
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H(+) ATPase, in two individuals with ZLS.
|
25915598 |
2015 |
Zimmerman Laband syndrome
|
0.610 |
GeneticVariation
|
disease |
BEFREE |
We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H(+) ATPase, in two individuals with ZLS.
|
25915598 |
2015 |
ZIMMERMANN-LABAND SYNDROME 2
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ATP6V1B2, which encodes the B2 subunit of the vacuolar H + ATPase have previously been associated with Zimmermann-Laband syndrome 2 (ZLS2) and deafness-onychodystrophy (DDOD) syndrome.
|
31655144 |
2019 |
ZIMMERMANN-LABAND SYNDROME 2
|
0.410 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome.
|
25915598 |
2015 |
ZIMMERMANN-LABAND SYNDROME 2
|
0.410 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
ZIMMERMANN-LABAND SYNDROME 2
|
0.410 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Lymphoma, Follicular
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
These data support the idea of mutational activation of autophagic flux by recurrent hotspot mutations in ATP6V1B2 as an adaptive mechanism in FL pathogenesis and as a possible new therapeutically targetable pathway.
|
30720463 |
2019 |
Lymphoma, Follicular
|
0.310 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Large-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Mixed-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Small Cleaved-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Follicular, Grade 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Follicular, Grade 3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Lymphoma, Follicular, Grade 2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
|
26691987 |
2016 |
Degenerative polyarthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance.
|
18784066 |
2009 |
Osteoarthrosis Deformans
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance.
|
18784066 |
2009 |
Dystrophia unguium
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ATP6V1B2, which encodes the B2 subunit of the vacuolar H + ATPase have previously been associated with Zimmermann-Laband syndrome 2 (ZLS2) and deafness-onychodystrophy (DDOD) syndrome.
|
31655144 |
2019 |